B Riley Lam Research · LRCX

B. Riley Lowers Lam Research Price Target to $350

1 min read Reproduced verbatim
Rating
Buy
Unchanged
Target
$350
from $385 (−9%)
Upside
+75%
LRCX at $200 today
B Riley and Lam Research logos

What the analyst said

B.Riley analyst Craig Ellis lowered the price target on Lam Research (NASDAQ: LRCX) to $350 (from $385) while maintaining a Buy rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LRCX trades at $200. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $350 target is in line with the median.

Since the note LRCX has moved −21% (from $252). 12-month window: day 99 of 365, closes on July 30, 2027.

Track record

This callOpen: LRCX has not reached $350 yet. This 12-month target is scored on July 30, 2027.

Firm track recordToo early to score B Riley: price targets are 12-month calls and fewer than 5 of its targets are a year old. 4 of its 16 open targets have already been reached. How we score

Earnings reactionOne of 4 notes after Lam Research’s Jul 29 results: 0 raised · 4 cut · 0 kept. See every call →

B Riley on Lam Research

B Riley price targets on Lam Research

4 calls from May 12, 2026 to October 19, 2026. The target went from $375 to $338 (−10%). The rating stayed Buy.

B Riley targetLRCX share price
  1. October 19, 2026Target cut from $390 (−13%)Buy$338
  2. October 1, 2026Target raised from $350 (+11%)Buy$390
  3. July 30, 2026 This noteTarget cut from $375 (−7%)Buy$350
  4. May 12, 2026Earliest call shownBuy$375
Share

Other analysts on Lam Research

Lynx Equity Kept rating and price target Oct 28 $400maintained BernsteinBuy Cut price target −9%, kept rating Oct 22 $350from $385 UBSBuy Cut price target −6%, kept rating Oct 22 $400from $425 Morgan StanleyBuy Cut price target −12%, kept rating Oct 22 $339from $385 Bank of AmericaBuy Cut price target −10%, kept rating Oct 22 $345from $385
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.